Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.8M Sell
95,697
-29,302
-23% -$2.91M 0.11% 171
2026
Q1
$11.8M Sell
124,999
-106,428
-46% -$10.6M 0.16% 131
2025
Q4
$22.9M Sell
231,427
-7,278
-3% -$704K 0.27% 77
2025
Q3
$20.2M Buy
238,705
+59,974
+34% +$4.74M 0.25% 82
2025
Q2
$12.2M Sell
178,731
-14,842
-8% -$940K 0.17% 110
2025
Q1
$11.7M Sell
193,573
-7,738
-4% -$540K 0.18% 112
2024
Q4
$13.9M Buy
+201,311
New +$14.3M 0.19% 112
2024
Q1
Sell
-7,012
Closed -$440K 363
2023
Q4
$440K Hold
7,012
0.01% 406
2023
Q3
$405K Buy
+7,012
New +$442K 0.01% 452

Other funds holding INCY

LBP AM's INCY Position: Q2 2026 in Review

LBP AM reduced its Incyte (INCY) stake by 23% in Q2 2026, selling an estimated $2.91M and leaving 95,697 shares worth $10.8M. The position accounts for 0.11% of the portfolio, ranked #171.

LBP AM first reported a position in INCY in Q3 2023 and has held it in 9 quarters since. The position peaked at $22.9M in Q4 2025. 858 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • LBP AM held 95,697 shares of Incyte worth $10.8M as of Q2 2026.
  • LBP AM sold 29,302 Incyte shares in Q2 2026, an estimated $2.91M.
  • Incyte made up 0.11% of LBP AM's portfolio in Q2 2026, its #171 holding.
  • LBP AM first reported a position in Incyte in Q3 2023 and has held it in 9 quarters since.
  • LBP AM's Incyte position peaked at $22.9M in Q4 2025.
  • 858 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on LBP AM's 13F filing for Q2 2026, filed 24 Jul 2026.